4th Quarter - Report

THE PETRIZZO GROUP, INC. for IBIO, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Advance iBio as the leader in plant-made pharmaceutical manufacturing and collaboration between the U.S. Government for research and manufacturing including funding for facilitization of domestic vaccine manufacturers that utilize agricultural cell line development for virus like particle based vaccines.

LobbyistCovered position, as disclosed
CAMILLE JUDITH LEPIRE New —
MEGAN CRISTINA PEREZ BURKE Legislative Director & Director Health Policy, Congresswoman Cathy McMorris Rodgers
TJ PETRIZZO —

Contacted: SENATE; Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Health Issues HCR

Advance iBio as the leader in plant-made pharmaceutical manufacturing and collaboration between the U.S. Government for research and manufacturing including funding for facilitization of domestic vaccine manufacturers that utilize agricultural cell line development for virus like particle based vaccines.

LobbyistCovered position, as disclosed
CAMILLE JUDITH LEPIRE Deputy Chief of Staff, Congressman Kevin Brady
MEGAN CRISTINA PEREZ BURKE Legislative Director & Health Policy Director, Congresswoman Cathy McMorris Rodgers
TJ PETRIZZO —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD)

Budget/Appropriations BUD

FY22 funding for advanced manufacturing technologies that utilize agricultural cell line development.

LobbyistCovered position, as disclosed
CAMILLE JUDITH LEPIRE New —
MEGAN CRISTINA PEREZ BURKE —
TJ PETRIZZO —

Contacted: Defense, Dept of (DOD); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.